{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T19:37:27Z","timestamp":1766086647005,"version":"3.40.4"},"reference-count":11,"publisher":"S. Karger AG","issue":"5","license":[{"start":{"date-parts":[[2010,1,1]],"date-time":"2010-01-01T00:00:00Z","timestamp":1262304000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.karger.com\/Services\/SiteLicenses"},{"start":{"date-parts":[[2010,1,1]],"date-time":"2010-01-01T00:00:00Z","timestamp":1262304000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.karger.com\/Services\/SiteLicenses"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Chemotherapy"],"published-print":{"date-parts":[[2010]]},"abstract":"<jats:p>&lt;i&gt;Aims:&lt;\/i&gt; To evaluate the clinical and bacterial efficacies and the safety of antofloxacin hydrochloride tablets in the treatment of acute exacerbations of chronic bronchitis (AECB) and acute pyelonephritis (AP). &lt;i&gt;Patients and Methods:&lt;\/i&gt; A randomized, controlled, multicenter, double-blind, double-dummy clinical trial was conducted at 6 hospitals in China. The patients in the investigational group took an oral 400-mg loading dose of antofloxacin on the first day followed by 200 mg daily. Control group patients took 200 mg of levofloxacin orally twice daily for 7\u201314 days. &lt;i&gt;Results:&lt;\/i&gt; A total of 284 patients were enrolled into the study, including 140 cases of AECB and 144 cases of AP; 141 patients were in the antofloxacin group and 143 patients were in the levofloxacin group. Two hundred fifty-four patients completed the entire treatment and follow-up and comprised the per-protocol analysis data set; 30 patients were excluded because of informed consent withdrawal, loss to follow-up, protocol violations, or adverse drug events. Treatment was ceased in 3 patients in the antofloxacin group and in 1 patient in the levofloxacin group because of skin rashes, dizziness, or adverse gastrointestinal effects. At the end of the 2-regimen treatment, the observed effectiveness rates for AECB were 90.3 and 87.7% for the treatment and control groups, respectively, and 96.9 and 92.1% for AP. The overall bacterial eradication rates were 95.9 and 92.4%, and drug-related adverse events were observed in 13.1 and 10.1% of patients, respectively. There were no severe adverse effects. No statistical differences in drug efficacy and safety were detected between the 2 treatment groups (p &gt; 0.05). &lt;i&gt;Conclusions:&lt;\/i&gt; Antofloxacin hydrochloride is an effective and well-tolerated new fluoroquinolone that demonstrates clinical and bacteriological efficacies similar to levofloxacin for the treatment of AECB and AP.<\/jats:p>","DOI":"10.1159\/000317581","type":"journal-article","created":{"date-parts":[[2010,10,13]],"date-time":"2010-10-13T10:35:18Z","timestamp":1286966118000},"page":"378-385","source":"Crossref","is-referenced-by-count":13,"title":["A Phase II Study of Antofloxacin Hydrochloride, a Novel Fluoroquinolone, for the Treatment of Acute Bacterial Infections"],"prefix":"10.1159","volume":"56","author":[{"given":"Jin","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yonghong","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenxiang","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chunxue","family":"Bai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qingyu","family":"Xiu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Changlin","family":"Mei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qingshan","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"127","published-online":{"date-parts":[[2010,10,12]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1002%2Fbdd.600"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1111%2Fj.1745-7254.2008.00872.x"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1378%2Fchest.125.3.953"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1093%2Fjac%2F43.4.529"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016%2FS0149-2918%2802%2985019-6"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1001%2Fjama.283.12.1583"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.2165%2F00003495-199957030-00007"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016%2FS0149-2918%2800%2980053-3"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1159%2F000099032"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1159%2F000224657"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016%2FS0378-4274%2801%2900509-4"}],"container-title":["Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.karger.com\/Article\/Pdf\/317581","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.karger.com\/Article\/Pdf\/317581","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T19:28:07Z","timestamp":1745436487000},"score":1,"resource":{"primary":{"URL":"https:\/\/karger.com\/article\/doi\/10.1159\/000317581"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010]]},"references-count":11,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2010,10,1]]},"published-print":{"date-parts":[[2010,12,22]]}},"URL":"https:\/\/doi.org\/10.1159\/000317581","archive":["Portico"],"relation":{},"ISSN":["0009-3157","1421-9794"],"issn-type":[{"type":"print","value":"0009-3157"},{"type":"electronic","value":"1421-9794"}],"subject":[],"published":{"date-parts":[[2010]]}}}